The trajectory of Sildenafil presents a complex picture for those considering investment. While the initial release generated significant gains, the lapse of its patent opened the floodgates to cheaper versions, https://bookmarkcolumn.com/story21430218/the-copyright-and-pharma-a-precarious-opportunity